ARCT
Arcturus Therapeutics Holdings Inc
14.40$
-2.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -295.7% | -94.4% | -3.5% | -131.8% | -31.0% | -449.3% | -1,092.7% | 15.5% | -11.5% | -43.2% | -110.5% | |
| – | 0.8% | 0.3% | 3.2% | 3.7% | 3.3% | 9.2% | 9.7% | 0.7% | 1.9% | 2.6% | 4.5% | |
| – | 38.5% | 12.3% | 16.7% | 8.0% | 9.5% | 70.9% | 234.0% | 14.9% | 22.0% | 27.5% | 37.8% | |
| – | 5.5% | 4.1% | 20.5% | 10.2% | 13.7% | 70.9% | 292.9% | – | – | – | – | |
| – | -18.2% | 13.1% | 56.7% | -7.3% | 76.9% | 222.4% | 264.0% | -6.1% | 4.7% | -15.0% | -58.3% | |
| – | 2.9% | 0.4% | 1.9% | 9.4% | 3.9% | 18.3% | 27.6% | 3.8% | 1.8% | 0.5% | 0.3% | |
| – | -551.4% | 23.9% | 79.7% | 140.5% | -3.9% | -18.3% | -27.6% | -3.8% | -1.8% | -0.5% | -0.3% | |
| – | 1,083.0% | 6.6% | 10.4% | 2.1% | 177.8% | 4,471.6% | 11.5% | – | – | – | – | |
| – | 30.7% | 27.7% | 43.5% | 62.7% | 23.8% | 488.5% | 377.0% | -2.4% | -17.3% | 0.0% | 0.0% | |
| – | 1,083.0% | 0.0% | 53.8% | 64.8% | 201.6% | 4,572.2% | 388.5% | -1.4% | -15.3% | 3.9% | 19.9% | |
| – | 235.9% | -70.4% | 130.0% | 73.5% | 166.6% | 4,104.6% | -731.7% | 10.4% | -28.6% | -39.7% | -90.9% | |
| – | -298.6% | -94.8% | -5.5% | -141.2% | -34.9% | -467.6% | -1,120.2% | 11.8% | -13.3% | -43.6% | -110.5% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.